Literature DB >> 19339467

Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Bente Olesen1, Flemming Scheutz, Megan Menard, Marianne N Skov, Hans Jørn Kolmos, Michael A Kuskowski, James R Johnson.   

Abstract

The successful Escherichia coli O15:K52:H1 clonal group provides a case study for the emergence of multiresistant clonal groups of Enterobacteriaceae generally. Accordingly, we tested the hypotheses that, over time, the O15:K52:H1 clonal group has become increasingly (i) virulent and (ii) resistant to antibiotics. One hundred archived international E. coli O15:K52:[H1] clinical isolates from 100 unique patients (1975 to 2006) were characterized for diverse phenotypic and molecular traits. All 100 isolates derived from phylogenetic group D and, presumptively, sequence type ST393. They uniformly carried the F16 papA allele and papG allele II (P fimbria structural subunit and adhesin variants), iha (adhesin-siderophore), fimH (type 1 fimbriae), fyuA (yersiniabactin receptor), iutA (aerobactin receptor), and kpsM II (group 2 capsule); 85% to 89% of them contained a complete copy of the pap operon and ompT (outer membrane protease). Slight additional virulence profile variation was evident, particularly within a minor diarrhea-associated subset (biotype C). However, in contrast to the clonal group's fairly stable virulence profiles over the past 30+ years, during the same interval the clonal group members' antimicrobial resistance profiles increased by a mean of 2.8 units per decade (P < 0.001). Moreover, the numbers of virulence genes and resistance markers were positively associated (P = 0.046), providing evidence against antimicrobial resistance and virulence being mutually exclusive in these strains. Thus, the O15:K52:H1 clonal group has become increasingly resistant to antimicrobials while maintaining (or expanding) its virulence potential, a particularly concerning trend if other emerging multiresistant enterobacterial clonal groups follow a similar pattern.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339467      PMCID: PMC2691114          DOI: 10.1128/JCM.00230-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules.

Authors:  F L Macrina; D J Kopecko; K R Jones; D J Ayers; S M McCowen
Journal:  Plasmid       Date:  1978-06       Impact factor: 3.466

2.  Evaluation of Minibact, a new system for rapid identification of Enterobacteriaceae. Comparison of Minibact, Micro-ID and API 20E with a conventional method as reference.

Authors:  P Kjaeldgaard; B Nissen; N Lange; H Laursen
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1986-04

3.  Epidemic multiresistant Escherichia coli infection in West Lambeth Health District.

Authors:  I Phillips; S Eykyn; A King; W R Gransden; B Rowe; J A Frost; R J Gross
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

4.  Cloned polynucleotide and synthetic oligonucleotide probes used in colony hybridization are equally efficient in the identification of enterotoxigenic Escherichia coli.

Authors:  H Sommerfelt; K H Kalland; P Raj; S L Moseley; M K Bhan; B Bjorvatn
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

5.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

6.  ColV plasmid-mediated, colicin V-independent iron uptake system of invasive strains of Escherichia coli.

Authors:  P H Williams; P J Warner
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Authors:  James R Johnson; Abby Gajewski; Alan J Lesse; Thomas A Russo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain.

Authors:  E J Threlfall; B Rowe; J L Ferguson; L R Ward
Journal:  J Hyg (Lond)       Date:  1986-12

9.  Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli.

Authors:  L Beutin; M A Montenegro; I Orskov; F Orskov; J Prada; S Zimmermann; R Stephan
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

10.  Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR.

Authors:  James R Johnson; Krista Owens; Montse Sabate; Guillem Prats
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more
  19 in total

1.  Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.

Authors:  James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

2.  Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

3.  Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection.

Authors:  Bente Olesen; Flemming Scheutz; Rebecca L Andersen; Megan Menard; Nadia Boisen; Brian Johnston; Dennis S Hansen; Karen A Krogfelt; James P Nataro; James R Johnson
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain.

Authors:  Pilar Cortés; Vanessa Blanc; Azucena Mora; Ghizlane Dahbi; Jesús E Blanco; Miguel Blanco; Cecilia López; Antonia Andreu; Ferran Navarro; María Pilar Alonso; Germán Bou; Jorge Blanco; Montserrat Llagostera
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

5.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Authors:  Bente Olesen; Dennis S Hansen; Frida Nilsson; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Flemming Scheutz; Brian Johnston; Karen A Krogfelt; James R Johnson
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

7.  Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim use.

Authors:  Martin Sundqvist; Susanne Granholm; Umaer Naseer; Patrik Rydén; Alma Brolund; Arnfinn Sundsfjord; Gunnar Kahlmeter; Anders Johansson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

8.  Molecular characterization of bacteremic Escherichia coli isolates in Romania.

Authors:  Codruţa-Romaniţa Usein; Raluca Papagheorghe; Mihaela Oprea; Maria Condei; Monica Strãuţ
Journal:  Folia Microbiol (Praha)       Date:  2015-10-09       Impact factor: 2.099

9.  Diversity and biofilm-production ability among isolates of Escherichia coli phylogroup D belonging to ST69, ST393 and ST405 clonal groups.

Authors:  Ângela Novais; Claudia Vuotto; João Pires; Carolina Montenegro; Gianfranco Donelli; Teresa M Coque; Luísa Peixe
Journal:  BMC Microbiol       Date:  2013-06-21       Impact factor: 3.605

10.  Clonal relatedness of enterotoxigenic Escherichia coli (ETEC) strains expressing LT and CS17 isolated from children with diarrhoea in La Paz, Bolivia.

Authors:  Claudia Rodas; John D Klena; Matilda Nicklasson; Volga Iniguez; Asa Sjöling
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.